Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Achyut Dahai
The Anti-Hiv Drug Nelfinavir Mesylate (Viracept) Is a Potent Inhibitor of Cell Fusion Caused by the SARS-CoV-2 Spike (S) Glycoprotein Warranting Further Evaluation as an Antiviral Against COVID-19 Infections
Related publications
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Hypothesis: Advanced Biotechnological Treatment Approaches Against SARS-CoV-2 (COVID-19)
Volume 5 - 2020, Issue 4 - April
Detection of Antibodies Against SARS-CoV-2 in Patients With COVID-19
Journal of Medical Virology
Virology
Infectious Diseases
Lessons Unfolding From Pediatric Cases of COVID-19 Disease Caused by SARS-CoV-2 Infection
Pediatric Pulmonology
Child Health
Pulmonary
Pediatrics
Perinatology
Respiratory Medicine
A SARS-CoV-2/COVID-19 Em Pacientes Com Câncer
Revista Brasileira de Cancerologia
Update on the SARS-CoV-2 (COVID-19) Outbreak: A Global Pandemic Challenge
Important Steps to Control COVID-19/SARS-CoV-2 Infection
SN Comprehensive Clinical Medicine
Call for Papers: The Pathophysiology of COVID-19 and SARS-CoV-2 Infection
American Journal of Physiology - Lung Cellular and Molecular Physiology
Pulmonary
Respiratory Medicine
Physiology
Cell Biology
Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (Mpro) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study